Managing MS during the COVID-19 pandemic

triMSx educational meeting, April 2020

This event focused on disease management and treatment in people with MS during the COVID-19 pandemic, with a focus on the following topics:

  • Virology
  • Epidemiology
  • Immune response and suppression
  • Disease-modifying therapies
  • MS services during the COVID-19 pandemic

The programme included short talks from experts around the globe followed by a panel discussion and Q&A session. would like to acknowledge F. Hoffmann-La Roche for providing an unrestricted educational grant for this triMSx COVID-19 event.


About this event

triMSx events are free educational initiatives linked to the conferences. Led by the Scientific Steering Committee, these events are webcasts of short presentations highlighting the latest research and clinical insights on a chosen topic.

For this triMSx event, the Committee chose the important topic of how to manage multiple sclerosis during the current COVID-19 pandemic. People with multiple sclerosis are facing increased risks and challenges during the COVID-19 pandemic, and they have many questions to which there are no easy answers:

  • ‘How will my immune system cope with COVID-19 infection?’
  • ‘What is my risk for severe infection or complications?’
  • ‘Should I stop my DMT … or delay treatment … or switch treatment?’
  • ‘Who will monitor my MS if my usual appointments are cancelled?’

Scientific programme (BST)


Welcome and introduction

Prof. Gavin Giovannoni, UK


What do we know about COVID-19 virology and epidemiology?

  • The virology of SARS-CoV2
  • General clinical overview of COVID-19
  • Epidemiology of COVID-19

Prof. Marco Salvetti, Italy


Where next for COVID-19 public health measures and timelines for treatment?

  • Immune response
  • Public health measures to deal with the pandemic
  • Timeline of anti-viral drugs and vaccine developments

Prof. Tony Cunningham, Australia


MS disease-modifying therapies

  • Immunosuppression and COVID-19

Associate Prof. Tomas Kalincik, Australia


MS disease-modifying therapies

  • How to use DMTs during the COVID-19 epidemic

Prof. Eva Havrdová, Czech Republic


MS services during the COVID-19 pandemic

  • Remote management of MS

Associate Prof. Anneke van der Walt, Australia


MS services during the COVID-19 pandemic

  • MS self-monitoring
  • Global data sharing - MS Data Alliance

Dr. Liesbet M Peeters, Belgium


Leadership and Innovation in a time of crisis- creating new pathways for blood monitoring

  • Remote pharmacovigilance

Ms Bernadette Porter, UK


Expert panel discussion and Q&A



Meeting close



0.49MB PDF

Speaker biographies